Jefferies & Co. advice for Dermapharm
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| March 17, 2025 | Jefferies & Co. | Dermapharm | Buy | 49.00 EUR | 25.00 % |
Advice details
New York - Op 17 maa herhalen de analisten van Jefferies & Co. hun koopadvies voor Dermapharm (ISIN: DE000A2GS5D8). Het 12-maands koersdoel blijft gehandhaafd op 49.0 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 